← Back to all trials
Completed
NCT07816575
Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque Psoriasis
Conditions: Psoriasis
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: Al-Azhar University
Location: Al-Hussien and cairo dermatology Hospital Cairo
Summary
The aim of this double blind comparative clinical study is to evaluate the efficacy of AHAs combined with nanocarriers and their use as a non steroidal alternative drug for long term management of plaque psoriasis
Eligibility Criteria
Inclusion Criteria:- Mid to moderate cases according to Psoriasis Area and Severity Index (PASI).
* Age from18-65 years old.
* Denovo psoriatic patients and patients with no psoriasis therapy in the previous two months.
Exclusion Criteria:
* Severe irritation and highly inflamed skin.
* Pregnant and lactating females.
* Patients with acute renal insufficiency.
* Face, flexural and groin lesions.
Source: ClinicalTrials.gov (NCT07816575). StuddyBuddy aggregates publicly available trial information.
